Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma

specific

The reemergence of primary cutaneous T-cell non-Hodgkin lymphoma after a period of remission.

26

Centers

21

Active Trials

Cancer Funding

Top Centers for Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma(26)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
173.6
2
NCI Comprehensive
Active Research Program
57.1
3
NCI Comprehensive
Active Research Program
57.1
4
NCI Comprehensive
Active Research Program
57.1
5
NCI Comprehensive
Active Research Program
57.1
6
NCI Comprehensive
Active Research Program
57.1
7
NCI Comprehensive
Active Research Program
57.1
8
NCI Comprehensive
Active Research Program
57.1
9
NCI Comprehensive
Active Research Program
57.1
10
NCI Comprehensive
Active Research Program
57.1
11
NCI Comprehensive
Active Research Program
57.1
12
NCI Comprehensive
Active Research Program
57.1
13
NCI Comprehensive
Active Research Program
57.1
14
NCI Clinical
Active Research Program
57.1
15
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
57.1
16
Active Research Program
57.1
17
Active Research Program
57.1
18
Active Research Program
57.1
19
BC CancerVancouver, BC
Active Research Program
57.1
20
NCI Comprehensive
35.5
21
NCI Comprehensive
35.5
22
NCI Comprehensive
35.5
23
NCI Comprehensive
35.5
2435.5
25
NCI Comprehensive
35.5
2635.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →